

# Table of Contents

 * [1 Sensitivity Analysis ](#sensitivity-analysis)
   * [1.1 Sensitivity Analysis for Raltegravir 10 mg (lactose formulation) ](#sensitivity-analysis-Raltegravir_10_mg__lactose_formulation_)
   * [1.2 Sensitivity Analysis for Raltegravir 25 mg (lactose formulation) ](#sensitivity-analysis-Raltegravir_25_mg__lactose_formulation_xxx)
   * [1.3 Sensitivity Analysis for Raltegravir 100 mg filmcoated tablet md ](#sensitivity-analysis-Raltegravir_100_mg_filmcoated_tablet_md)
 * [2 PK parameters ](#pk-parameters)
   * [2.1 PK parameters for Raltegravir 10 mg (lactose formulation) ](#pk-parameters-Raltegravir_10_mg__lactose_formulation_)
   * [2.2 PK parameters for Raltegravir 25 mg (lactose formulation) ](#pk-parameters-Raltegravir_25_mg__lactose_formulation_)
   * [2.3 PK parameters for Raltegravir 100 mg filmcoated tablet md ](#pk-parameters-Raltegravir_100_mg_filmcoated_tablet_md)
 * [3 Absorption ](#absorption)
   * [3.1 Absorption for Raltegravir 10 mg (lactose formulation) ](#absorption-Raltegravir_10_mg__lactose_formulation_)
   * [3.2 Absorption for Raltegravir 25 mg (lactose formulation) ](#absorption-Raltegravir_25_mg__lactose_formulation_)
   * [3.3 Absorption for Raltegravir 100 mg filmcoated tablet md ](#absorption-Raltegravir_100_mg_filmcoated_tablet_md)
 * [4 Mass Balance ](#mass-balance)
   * [4.1 Mass Balance for Raltegravir 10 mg (lactose formulation) ](#mass-balance-Raltegravir_10_mg__lactose_formulation_)
   * [4.2 Mass Balance for Raltegravir 25 mg (lactose formulation) ](#mass-balance-Raltegravir_25_mg__lactose_formulation_)
   * [4.3 Mass Balance for Raltegravir 100 mg filmcoated tablet md ](#mass-balance-Raltegravir_100_mg_filmcoated_tablet_md)
 * [5 Time profiles and residual plots ](#time-profiles)
   * [5.1 Time profiles and residual plots for Raltegravir 10 mg (lactose formulation) ](#time-profiles-Raltegravir_10_mg__lactose_formulation_)
   * [5.2 Time profiles and residual plots for Raltegravir 25 mg (lactose formulation) ](#time-profiles-Raltegravir_25_mg__lactose_formulation_)
   * [5.3 Time profiles and residual plots for Raltegravir 100 mg filmcoated tablet md ](#time-profiles-Raltegravir_100_mg_filmcoated_tablet_md)
     * [5.3.1 For total simulation time range ](#goodness-of-fit-Raltegravir_100_mg_filmcoated_tablet_md-total)
     * [5.3.2 For first application range ](#goodness-of-fit-Raltegravir_100_mg_filmcoated_tablet_md-first)
     * [5.3.3 For last application range ](#goodness-of-fit-Raltegravir_100_mg_filmcoated_tablet_md-last)
   * [5.4 Residuals across all simulations ](#time-profiles-residuals-across-all-simulations)





# 1 Sensitivity Analysis <a id="sensitivity-analysis"></a>


## 1.1 Sensitivity Analysis for Raltegravir 10 mg (lactose formulation) <a id="sensitivity-analysis-Raltegravir_10_mg__lactose_formulation_"></a>


<a id="figure-1-1"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-1_sensitivity_C_max.png)



**Figure 1-1: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-2"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-2_sensitivity_t_max.png)



**Figure 1-2: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-3"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-3_sensitivity_C_tEnd.png)



**Figure 1-3: Most sensitive parameters for C_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-4"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-4_sensitivity_AUC_tEnd.png)



**Figure 1-4: Most sensitive parameters for AUC of Raltegravir.**


<br>
<br>


<a id="figure-1-5"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-5_sensitivity_AUC_inf.png)



**Figure 1-5: Most sensitive parameters for AUC_inf of Raltegravir.**


<br>
<br>


<a id="figure-1-6"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-6_sensitivity_MRT.png)



**Figure 1-6: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-7"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-7_sensitivity_Thalf.png)



**Figure 1-7: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-8"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-8_sensitivity_CL.png)



**Figure 1-8: Most sensitive parameters for CL of Raltegravir.**


<br>
<br>


<a id="figure-1-9"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-9_sensitivity_Vss.png)



**Figure 1-9: Most sensitive parameters for Vss of Raltegravir.**


<br>
<br>


<a id="figure-1-10"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-10_sensitivity_Vd.png)



**Figure 1-10: Most sensitive parameters for Vd of Raltegravir.**


<br>
<br>


## 1.2 Sensitivity Analysis for Raltegravir 25 mg (lactose formulation) <a id="sensitivity-analysis-Raltegravir_25_mg__lactose_formulation_xxx"></a>


<a id="figure-1-11"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-1_sensitivity_C_max.png)



**Figure 1-11: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-12"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-2_sensitivity_t_max.png)



**Figure 1-12: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-13"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-3_sensitivity_C_tEnd.png)



**Figure 1-13: Most sensitive parameters for C_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-14"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-4_sensitivity_AUC_tEnd.png)



**Figure 1-14: Most sensitive parameters for AUC of Raltegravir.**


<br>
<br>


<a id="figure-1-15"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-5_sensitivity_AUC_inf.png)



**Figure 1-15: Most sensitive parameters for AUC_inf of Raltegravir.**


<br>
<br>


<a id="figure-1-16"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-6_sensitivity_MRT.png)



**Figure 1-16: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-17"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-7_sensitivity_Thalf.png)



**Figure 1-17: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-18"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-8_sensitivity_CL.png)



**Figure 1-18: Most sensitive parameters for CL of Raltegravir.**


<br>
<br>


<a id="figure-1-19"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-9_sensitivity_Vss.png)



**Figure 1-19: Most sensitive parameters for Vss of Raltegravir.**


<br>
<br>


<a id="figure-1-20"></a>

![](Sensitivity/Raltegravir_25_mg__lactose_formulation_-10_sensitivity_Vd.png)



**Figure 1-20: Most sensitive parameters for Vd of Raltegravir.**


<br>
<br>


## 1.3 Sensitivity Analysis for Raltegravir 100 mg filmcoated tablet md <a id="sensitivity-analysis-Raltegravir_100_mg_filmcoated_tablet_md"></a>


<a id="figure-1-21"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-1_sensitivity_C_max.png)



**Figure 1-21: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-22"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-2_sensitivity_C_max_tD1_tD2.png)



**Figure 1-22: Most sensitive parameters for C_max_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-23"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-3_sensitivity_C_max_tDLast_tEnd.png)



**Figure 1-23: Most sensitive parameters for C_max_tLast_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-24"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-4_sensitivity_t_max.png)



**Figure 1-24: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-25"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-5_sensitivity_t_max_tD1_tD2.png)



**Figure 1-25: Most sensitive parameters for t_max_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-26"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-6_sensitivity_t_max_tDLast_tEnd.png)



**Figure 1-26: Most sensitive parameters for t_max_tLast_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-27"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-7_sensitivity_C_trough_tD2.png)



**Figure 1-27: Most sensitive parameters for C_trough_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-28"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-8_sensitivity_C_trough_tDLast.png)



**Figure 1-28: Most sensitive parameters for C_trough_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-29"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-9_sensitivity_AUC_tD1_tD2.png)



**Figure 1-29: Most sensitive parameters for AUC_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-30"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-10_sensitivity_AUC_tDLast_minus_1_tDLast.png)



**Figure 1-30: Most sensitive parameters for AUC_tLast_minus_1_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-31"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-11_sensitivity_AUC_inf_tD1.png)



**Figure 1-31: Most sensitive parameters for AUC_inf_t1 of Raltegravir.**


<br>
<br>


<a id="figure-1-32"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-12_sensitivity_AUC_inf_tDLast.png)



**Figure 1-32: Most sensitive parameters for AUC_inf_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-33"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-13_sensitivity_MRT.png)



**Figure 1-33: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-34"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-14_sensitivity_Thalf.png)



**Figure 1-34: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-35"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-15_sensitivity_Thalf_tDLast_tEnd.png)



**Figure 1-35: Most sensitive parameters for Thalf_tLast_tEnd of Raltegravir.**


<br>
<br>





# 2 PK parameters <a id="pk-parameters"></a>


## 2.1 PK parameters for Raltegravir 10 mg (lactose formulation) <a id="pk-parameters-Raltegravir_10_mg__lactose_formulation_"></a>


<a id="table-2-1"></a>

**Table 2-1: PK parameters for Raltegravir 10 mg (lactose formulation)**


|Path        |Parameter    |Value   |Unit      |
|:-----------|:------------|:-------|:---------|
|Raltegravir |C_max        |110.49  |µg/l      |
|Raltegravir |C_max_norm   |0.81    |kg/l      |
|Raltegravir |t_max        |0.75    |h         |
|Raltegravir |C_tEnd       |1.96    |µg/l      |
|Raltegravir |AUC          |241.61  |µg*h/l    |
|Raltegravir |AUC_norm     |1.76    |kg*h/l    |
|Raltegravir |AUC_inf      |255.14  |µg*h/l    |
|Raltegravir |AUC_inf_norm |1.86    |kg*h/l    |
|Raltegravir |MRT          |3.33    |h         |
|Raltegravir |Thalf        |4.79    |h         |
|Raltegravir |CL           |8.95    |ml/min/kg |
|Raltegravir |Vss          |1787.57 |ml/kg     |
|Raltegravir |Vd           |3713.90 |ml/kg     |


<br>
<br>


## 2.2 PK parameters for Raltegravir 25 mg (lactose formulation) <a id="pk-parameters-Raltegravir_25_mg__lactose_formulation_"></a>


<a id="table-2-2"></a>

**Table 2-2: PK parameters for Raltegravir 25 mg (lactose formulation)**


|Path        |Parameter    |Value   |Unit      |
|:-----------|:------------|:-------|:---------|
|Raltegravir |C_max        |276.85  |µg/l      |
|Raltegravir |C_max_norm   |0.81    |kg/l      |
|Raltegravir |t_max        |0.75    |h         |
|Raltegravir |C_tEnd       |4.89    |µg/l      |
|Raltegravir |AUC          |605.06  |µg*h/l    |
|Raltegravir |AUC_norm     |1.77    |kg*h/l    |
|Raltegravir |AUC_inf      |638.90  |µg*h/l    |
|Raltegravir |AUC_inf_norm |1.87    |kg*h/l    |
|Raltegravir |MRT          |3.33    |h         |
|Raltegravir |Thalf        |4.79    |h         |
|Raltegravir |CL           |8.93    |ml/min/kg |
|Raltegravir |Vss          |1783.40 |ml/kg     |
|Raltegravir |Vd           |3705.77 |ml/kg     |


<br>
<br>


## 2.3 PK parameters for Raltegravir 100 mg filmcoated tablet md <a id="pk-parameters-Raltegravir_100_mg_filmcoated_tablet_md"></a>


<a id="table-2-3"></a>

**Table 2-3: PK parameters for Raltegravir 100 mg filmcoated tablet md**


|Path        |Parameter                    |Value   |Unit   |
|:-----------|:----------------------------|:-------|:------|
|Raltegravir |C_max                        |893.50  |µg/l   |
|Raltegravir |C_max_norm                   |0.03    |kg/l   |
|Raltegravir |C_max_t1_t2                  |863.16  |µg/l   |
|Raltegravir |C_max_t1_t2_norm             |0.63    |kg/l   |
|Raltegravir |C_max_tLast_tEnd             |892.65  |µg/l   |
|Raltegravir |C_max_tLast_tEnd_norm        |0.65    |kg/l   |
|Raltegravir |t_max                        |168.75  |h      |
|Raltegravir |t_max_t1_t2                  |0.75    |h      |
|Raltegravir |t_max_tLast_tEnd             |228.75  |h      |
|Raltegravir |C_trough_t2                  |19.66   |µg/l   |
|Raltegravir |C_trough_tLast               |31.92   |µg/l   |
|Raltegravir |AUC_t1_t2                    |1978.76 |µg*h/l |
|Raltegravir |AUC_t1_t2_norm               |1.44    |kg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast      |2218.73 |µg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast_norm |1.62    |kg*h/l |
|Raltegravir |AUC_inf_t1                   |2144.35 |µg*h/l |
|Raltegravir |AUC_inf_t1_norm              |1.57    |kg*h/l |
|Raltegravir |AUC_inf_tLast                |2536.55 |µg*h/l |
|Raltegravir |AUC_inf_tLast_norm           |1.85    |kg*h/l |
|Raltegravir |MRT                          |3.96    |h      |
|Raltegravir |Thalf                        |5.84    |h      |
|Raltegravir |Thalf_tLast_tEnd             |6.90    |h      |


<br>
<br>





# 3 Absorption <a id="absorption"></a>


## 3.1 Absorption for Raltegravir 10 mg (lactose formulation) <a id="absorption-Raltegravir_10_mg__lactose_formulation_"></a>


<a id="figure-3-1"></a>

![](Absorption/Raltegravir_10_mg__lactose_formulation_-1_absorption_Raltegravir.png)



**Figure 3-1: Absorption of Raltegravir**


<br>
<br>


## 3.2 Absorption for Raltegravir 25 mg (lactose formulation) <a id="absorption-Raltegravir_25_mg__lactose_formulation_"></a>


<a id="figure-3-2"></a>

![](Absorption/Raltegravir_25_mg__lactose_formulation_-1_absorption_Raltegravir.png)



**Figure 3-2: Absorption of Raltegravir**


<br>
<br>


## 3.3 Absorption for Raltegravir 100 mg filmcoated tablet md <a id="absorption-Raltegravir_100_mg_filmcoated_tablet_md"></a>


<a id="figure-3-3"></a>

![](Absorption/Raltegravir_100_mg_filmcoated_tablet_md-1_absorption_Raltegravir.png)



**Figure 3-3: Absorption of Raltegravir**


<br>
<br>





# 4 Mass Balance <a id="mass-balance"></a>


## 4.1 Mass Balance for Raltegravir 10 mg (lactose formulation) <a id="mass-balance-Raltegravir_10_mg__lactose_formulation_"></a>


<a id="figure-4-1"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-1_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-1: Amount of drug vs time within the different compartments**


<br>
<br>


<a id="figure-4-2"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-2_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-2: Cumulated amount of drug vs time within the different compartments**


<br>
<br>


<a id="figure-4-3"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-3_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-3: Amount of drug vs time within the different compartments normalized to applicated drugmass**


<br>
<br>


<a id="figure-4-4"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-4_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-4: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass**


<br>
<br>


<a id="figure-4-5"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-5_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-5: Fraction of drug within the different compartments at 12.00h**


<br>
<br>


## 4.2 Mass Balance for Raltegravir 25 mg (lactose formulation) <a id="mass-balance-Raltegravir_25_mg__lactose_formulation_"></a>


<a id="figure-4-6"></a>

![](MassBalance/Raltegravir_25_mg__lactose_formulation_-1_mass_balance_Raltegravir_25_mg__lactose_formulation_.png)



**Figure 4-6: Amount of drug vs time within the different compartments**


<br>
<br>


<a id="figure-4-7"></a>

![](MassBalance/Raltegravir_25_mg__lactose_formulation_-2_mass_balance_Raltegravir_25_mg__lactose_formulation_.png)



**Figure 4-7: Cumulated amount of drug vs time within the different compartments**


<br>
<br>


<a id="figure-4-8"></a>

![](MassBalance/Raltegravir_25_mg__lactose_formulation_-3_mass_balance_Raltegravir_25_mg__lactose_formulation_.png)



**Figure 4-8: Amount of drug vs time within the different compartments normalized to applicated drugmass**


<br>
<br>


<a id="figure-4-9"></a>

![](MassBalance/Raltegravir_25_mg__lactose_formulation_-4_mass_balance_Raltegravir_25_mg__lactose_formulation_.png)



**Figure 4-9: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass**


<br>
<br>


<a id="figure-4-10"></a>

![](MassBalance/Raltegravir_25_mg__lactose_formulation_-5_mass_balance_Raltegravir_25_mg__lactose_formulation_.png)



**Figure 4-10: Fraction of drug within the different compartments at 12.00h**


<br>
<br>


## 4.3 Mass Balance for Raltegravir 100 mg filmcoated tablet md <a id="mass-balance-Raltegravir_100_mg_filmcoated_tablet_md"></a>


<a id="figure-4-11"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-1_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-11: Amount of drug vs time within the different compartments**


<br>
<br>


<a id="figure-4-12"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-2_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-12: Cumulated amount of drug vs time within the different compartments**


<br>
<br>


<a id="figure-4-13"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-3_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-13: Amount of drug vs time within the different compartments normalized to applicated drugmass**


<br>
<br>


<a id="figure-4-14"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-4_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-14: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass**


<br>
<br>


<a id="figure-4-15"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-5_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-15: Fraction of drug within the different compartments at 240.00h**


<br>
<br>





# 5 Time profiles and residual plots <a id="time-profiles"></a>


## 5.1 Time profiles and residual plots for Raltegravir 10 mg (lactose formulation) <a id="time-profiles-Raltegravir_10_mg__lactose_formulation_"></a>


<a id="figure-5-1"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-3_timeProfile_Concentration_total.png)



**Figure 5-1: Time profiles for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-2"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-4_timeProfileLog_Concentration_total.png)



**Figure 5-2: Time profiles for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-3"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-5_obsVsPred_Concentration_total.png)



**Figure 5-3: Predicted vs observed for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-4"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-6_obsVsPredLog_Concentration_total.png)



**Figure 5-4: Predicted vs observed for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-5"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-7_resVsPred_total.png)



**Figure 5-5: Logarithmic residuals vs predicted values for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-6"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-8_resVsTime_total.png)



**Figure 5-6: Logarithmic residuals vs time values for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-7"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-9_resHisto_total.png)



**Figure 5-7: Logarithmic residuals distribution (stacked) for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-8"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-10_resQQPlot_total.png)



**Figure 5-8: Logarithmic residuals for Raltegravir 10 mg (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.2 Time profiles and residual plots for Raltegravir 25 mg (lactose formulation) <a id="time-profiles-Raltegravir_25_mg__lactose_formulation_"></a>


<a id="figure-5-9"></a>

![](TimeProfiles/Raltegravir_25_mg__lactose_formulation_-3_timeProfile_Concentration_total.png)



**Figure 5-9: Time profiles for Raltegravir 25 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-10"></a>

![](TimeProfiles/Raltegravir_25_mg__lactose_formulation_-4_timeProfileLog_Concentration_total.png)



**Figure 5-10: Time profiles for Raltegravir 25 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-11"></a>

![](TimeProfiles/Raltegravir_25_mg__lactose_formulation_-5_obsVsPred_Concentration_total.png)



**Figure 5-11: Predicted vs observed for Raltegravir 25 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-12"></a>

![](TimeProfiles/Raltegravir_25_mg__lactose_formulation_-6_obsVsPredLog_Concentration_total.png)



**Figure 5-12: Predicted vs observed for Raltegravir 25 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-13"></a>

![](TimeProfiles/Raltegravir_25_mg__lactose_formulation_-7_resVsPred_total.png)



**Figure 5-13: Logarithmic residuals vs predicted values for Raltegravir 25 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-14"></a>

![](TimeProfiles/Raltegravir_25_mg__lactose_formulation_-8_resVsTime_total.png)



**Figure 5-14: Logarithmic residuals vs time values for Raltegravir 25 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-15"></a>

![](TimeProfiles/Raltegravir_25_mg__lactose_formulation_-9_resHisto_total.png)



**Figure 5-15: Logarithmic residuals distribution (stacked) for Raltegravir 25 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-16"></a>

![](TimeProfiles/Raltegravir_25_mg__lactose_formulation_-10_resQQPlot_total.png)



**Figure 5-16: Logarithmic residuals for Raltegravir 25 mg (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.3 Time profiles and residual plots for Raltegravir 100 mg filmcoated tablet md <a id="time-profiles-Raltegravir_100_mg_filmcoated_tablet_md"></a>


### 5.3.1 For total simulation time range <a id="goodness-of-fit-Raltegravir_100_mg_filmcoated_tablet_md-total"></a>


<a id="figure-5-17"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-4_timeProfile_Concentration_total.png)



**Figure 5-17: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-18"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-5_timeProfileLog_Concentration_total.png)



**Figure 5-18: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-19"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-6_obsVsPred_Concentration_total.png)



**Figure 5-19: Predicted vs observed for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-20"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-7_obsVsPredLog_Concentration_total.png)



**Figure 5-20: Predicted vs observed for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-21"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-8_resVsPred_total.png)



**Figure 5-21: Logarithmic residuals vs predicted values for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-22"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-9_resVsTime_total.png)



**Figure 5-22: Logarithmic residuals vs time values for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-23"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-10_resHisto_total.png)



**Figure 5-23: Logarithmic residuals distribution (stacked) for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-24"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-11_resQQPlot_total.png)



**Figure 5-24: Logarithmic residuals for Raltegravir 100 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


### 5.3.2 For first application range <a id="goodness-of-fit-Raltegravir_100_mg_filmcoated_tablet_md-first"></a>


<a id="figure-5-25"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-13_timeProfile_Concentration_firstApplication.png)



**Figure 5-25: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-26"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-14_timeProfileLog_Concentration_firstApplication.png)



**Figure 5-26: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


### 5.3.3 For last application range <a id="goodness-of-fit-Raltegravir_100_mg_filmcoated_tablet_md-last"></a>


<a id="figure-5-27"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-16_timeProfile_Concentration_lastApplication.png)



**Figure 5-27: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-28"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-17_timeProfileLog_Concentration_lastApplication.png)



**Figure 5-28: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-29"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-18_obsVsPred_Concentration_lastApplication.png)



**Figure 5-29: Predicted vs observed for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-30"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-19_obsVsPredLog_Concentration_lastApplication.png)



**Figure 5-30: Predicted vs observed for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-31"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-20_resVsPred_lastApplication.png)



**Figure 5-31: Logarithmic residuals vs predicted values for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-32"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-21_resVsTime_lastApplication.png)



**Figure 5-32: Logarithmic residuals vs time values for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-33"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-22_resHisto_lastApplication.png)



**Figure 5-33: Logarithmic residuals distribution (stacked) for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-34"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-23_resQQPlot_lastApplication.png)



**Figure 5-34: Logarithmic residuals for Raltegravir 100 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.4 Residuals across all simulations <a id="time-profiles-residuals-across-all-simulations"></a>


<a id="figure-5-35"></a>

![](TimeProfiles/residuals_across_all_simulations_1_obsVsPred_Organism_PeripheralVenousBlood_Raltegravir_Plasma__Peripheral_Venous_Blood_.png)



**Figure 5-35: Predicted vs observed for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 25 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-36"></a>

![](TimeProfiles/residuals_across_all_simulations_2_obsVsPredLog_Organism_PeripheralVenousBlood_Raltegravir_Plasma__Peripheral_Venous_Blood_.png)



**Figure 5-36: Predicted vs observed for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 25 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-37"></a>

![](TimeProfiles/residuals_across_all_simulations_3_res_vs_pred.png)



**Figure 5-37: Logarithmic residuals vs predicted values for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 25 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md**


<br>
<br>


<a id="figure-5-38"></a>

![](TimeProfiles/residuals_across_all_simulations_4_res_vs_time.png)



**Figure 5-38: Logarithmic residuals vs time values for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 25 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md**


<br>
<br>


<a id="figure-5-39"></a>

![](TimeProfiles/residuals_across_all_simulations_5_histogram.png)



**Figure 5-39: Logarithmic residuals distribution (stacked) for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 25 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md**


<br>
<br>


<a id="figure-5-40"></a>

![](TimeProfiles/residuals_across_all_simulations_6_qq_plot.png)



**Figure 5-40: Logarithmic residuals for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 25 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md as quantile-quantile plot**


<br>
<br>



